- Opthea to Receive US$35M Commitment and Additional US$50M Funding
- Opthea Receives A$8.8 million R&D Tax Incentive
- Opthea to Present at the FLORetina 2023 Congress
- Opthea to Present at the Jefferies 2023 London Healthcare Conference
- Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference
- Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO
More ▼
Key statistics
As of last trade Opthea Ltd (OPT:ASX) traded at 0.62, -23.93% below its 52-week high of 0.815, set on Apr 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.605 |
---|---|
High | 0.63 |
Low | 0.605 |
Bid | 0.615 |
Offer | 0.62 |
Previous close | 0.61 |
Average volume | 606.78k |
---|---|
Shares outstanding | 662.81m |
Free float | 625.11m |
P/E (TTM) | -- |
Market cap | 410.94m AUD |
EPS (TTM) | -0.4786 AUD |
Data delayed at least 20 minutes, as of May 03 2024 05:05 BST.
More ▼